Closing Bell: Briacell Therapeutics Corp down on Wednesday (BCT)

In market activity today, shares of Briacell Therapeutics Corp opened at $0.79 and closed at $0.79. prices ranged from $0.79 to $0.79.

Share prices eased -7.06% from the previous day's close of $0.85.

Today across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.

Briacell Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker BCT.

A total of 2,531 shares was traded during the last trading day, with total trades of 8, with an average volume of 3,262 in the last five days.

The TSX market on the whole today saw 1,858 price advancers against 3,319 declines and 108 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.79 (August 07,2024). Moreover, the shares have plummeted -91.10% in 52 weeks, while they have plummeted -89.87% this year.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $15.54 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a None company headquartered in Vancouver, CAN.

Briacell Therapeutics Corp's average recommendation is "Strong Buy" based on 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..